EvoBiologics Information

Evolutionary Biologics develops precision regenerative biologics designed to support skin health, hair restoration, recovery optimization, and systemic wellbeing through advanced exosome signaling. Our products are manufactured in FDA-registered U.S. tissue facilities utilizing cGMP-compliant processing standards, cryopreservation protocols, and third-party testing measures. We prioritize indication-specific sourcing, non-lyophilized preservation, and Certificate of Analysis documentation with every order to help providers maintain consistency, quality, and confidence across protocols. The Evo Bio portfolio was built around targeted regenerative applications. From dermal fibroblast exosomes designed for skin quality and post-procedure recovery, to MSC-derived dermal papilla exosomes for hair restoration, to broad-spectrum Wharton’s Jelly signaling support — each formulation is selected with purpose and protocol performance in mind. Beyond products, Evolutionary Biologics is committed to advancing provider education, regenerative innovation, and clinically informed protocol development through strategic partnerships, ongoing research, and industry collaboration.